UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent progress in TGF-β inhibitors for cancer therapy

Biomedicine & pharmacotherapy, 2021-02, Vol.134, p.111046-111046, Article 111046

2021

Volltextzugriff (PDF)

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.1795-1808

2021

Volltextzugriff (PDF)

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients

Journal of viral hepatitis, 2021-08, Vol.28 (8), p.1141-1149

2021

Volltextzugriff (PDF)

Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients

The Journal of infectious diseases, 2022-06, Vol.225 (11), p.1974-1981

2022

Volltextzugriff (PDF)

Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement

Critical care (London, England), 2021-08, Vol.25 (1), p.282-282, Article 282

2021

Volltextzugriff (PDF)

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

Journal of gastroenterology and hepatology, 2017-12, Vol.32 (12), p.1975-1981

2017

Volltextzugriff (PDF)

The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy

The Journal of infectious diseases, 2019-04, Vol.219 (10), p.1624-1633

2019

Volltextzugriff (PDF)

HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria

The Journal of biological chemistry, 2023-11, Vol.299 (11), p.105335, Article 105335

2023

Volltextzugriff (PDF)

The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection

World journal of surgery, 2020, Vol.44 (1), p.247-257

2020

Volltextzugriff (PDF)

Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients

Digestive diseases and sciences, 2020-07, Vol.65 (7), p.2130-2139

2020

Volltextzugriff (PDF)

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery

Scientific reports, 2020-04, Vol.10 (1), p.7290-7290, Article 7290

2020

Volltextzugriff (PDF)

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

International journal of cancer, 2016-02, Vol.138 (3), p.714-720

2016

Volltextzugriff (PDF)

How symptoms of prolonged grief disorder, posttraumatic stress disorder, and depression relate to each other for grieving ICU families during the first two years of bereavement

Critical care (London, England), 2022-11, Vol.26 (1), p.1-336, Article 336

2022

Volltextzugriff (PDF)

ICU bereaved surrogates' comorbid psychological-distress states and their associations with prolonged grief disorder

Critical care (London, England), 2022-04, Vol.26 (1), p.102-102, Article 102

2022

Volltextzugriff (PDF)

Real‐world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan

Journal of viral hepatitis, 2020-09, Vol.27 (9), p.866-872

2020

Volltextzugriff (PDF)

Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience

Journal of viral hepatitis, 2019-12, Vol.26 (12), p.1404-1412

2019

Volltextzugriff (PDF)

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment

Investigational new drugs, 2020-02, Vol.38 (1), p.202-210

2020

Volltextzugriff (PDF)

Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan

Hepatology (Baltimore, Md.), 2014-05, Vol.59 (5), p.1840-1849

2014

Volltextzugriff (PDF)

Microalgal extract from thermotolerant Coelastrella sp. F50 retards the liver tumor progression by targeting hepatic cancer stem cells

Phytotherapy research, 2021-07, Vol.35 (7), p.3954-3967

2021

Volltextzugriff (PDF)

Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy

Liver international, 2016-12, Vol.36 (12), p.1793-1799

2016

Volltextzugriff (PDF)

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy

International journal of cancer, 2011-05, Vol.128 (10), p.2344-2352

2011

Volltextzugriff (PDF)

Clinical and novel application of FibroScan, FIB‐4 and aspartate aminotransferase‐to‐platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction

International journal of clinical practice (Esher), 2021-04, Vol.75 (4), p.e13945-n/a

2021

Volltextzugriff (PDF)

MicroRNAs in Hepatocellular Carcinoma : Carcinogenesis, Progression, and Therapeutic Target

BioMed research international, 2014-01, Vol.2014 (2014), p.1-11

2014

Volltextzugriff (PDF)

BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling

Laboratory investigation, 2018-08, Vol.98 (8), p.999-1013

2018

Volltextzugriff (PDF)

Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation

Hepatology international, 2021-04, Vol.15 (2), p.301-309

2021

Volltextzugriff (PDF)

1 – 25 von 280

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(258)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recent progress in TGF-β inhibitors for cancer therapy

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients

Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients

Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy

HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria

The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection

Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

How symptoms of prolonged grief disorder, posttraumatic stress disorder, and depression relate to each other for grieving ICU families during the first two years of bereavement

ICU bereaved surrogates' comorbid psychological-distress states and their associations with prolonged grief disorder

Real‐world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan

Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment

Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan

Microalgal extract from thermotolerant Coelastrella sp. F50 retards the liver tumor progression by targeting hepatic cancer stem cells

Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy

Clinical and novel application of FibroScan, FIB‐4 and aspartate aminotransferase‐to‐platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction

MicroRNAs in Hepatocellular Carcinoma : Carcinogenesis, Progression, and Therapeutic Target

BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling

Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation

Aktive Filter

Suchergebnisse filtern